| 1 |
|
| 2 |
Zhi N , Ren R , Qi J , Liu X , Yun Z , Lin S , Hu Y , Li H , Xie X , Wang J , Li J , Zhu Y , Gao M , Yang J , Wang Y , Jing Y , Geng J , Cao W , Xu Q , Yu X , Zhu Y , Zhou Y , Wang L , Gao C , Li B , Chen S , Yuan F , Dou R , Liu X , Li X , Yin Y , Chang Y , Xu G , Zhong Y , Li C , Wang Y , Zhou M , Wang G . The China Alzheimer report 2025. Gen Psychiatr, 2025, 38: e102020.
doi: 10.1136/gpsych-2024-102020
|
| 3 |
Gan J , Zeng Y , Huang G , Wang XD , Lü Y , Niu J , Meng X , Cai P , Li X , Li Y , Shen L , You Y , Gang B , Tang Y , Lv Y , Ren Z , Liu S , Ji Y . The updated prevalence and risk factors of dementia in old adults in China: a cross-sectional study. J Alzheimers Dis, 2024, 102: 1209- 1223.
doi: 10.1177/13872877241297155
|
| 4 |
Carson N , Leach L , Murphy KJ . A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores. Int J Geriatr Psychiatry, 2018, 33: 379- 388.
doi: 10.1002/gps.4756
|
| 5 |
Ciesielska N , Sokołowski R , Mazur E , Podhorecka M , Polak-Szabela A , Kędziora-Kornatowska K . Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60: Meta-analysis?. Psychiatr Pol, 2016, 50: 1039- 1052.
doi: 10.12740/PP/45368
|
| 6 |
Shulman KI . Clock-drawing: is it the ideal cognitive screening test?. Int J Geriatr Psychiatry, 2000, 15: 548- 561.
doi: 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U
|
| 7 |
Chinese Society of Dementia and Cognitive Impairment . Chinese expert consensus on the diagnosis and treatment of mild cognitive impairment due to Alzheimer's disease 2024. Zhonghua Shen Jing Ke Za Zhi, 2024, 57: 715- 737.
|
|
中华医学会神经病学分会痴呆与认知障碍学组. 阿尔茨海默病源性轻度认知障碍诊疗中国专家共识2024. 中华神经科杂志, 2024, 57: 715- 737.
|
| 8 |
O'Reilly-Shah VN , Hemani S , Davari P , Glowka L , Gebhardt E , Hill L , Lee S , Master VA , Rodriguez AD , García PS . A preoperative cognitive screening test predicts increased length of stay in a frail population: a retrospective case-control study. Anesth Analg, 2019, 129: 1283- 1290.
doi: 10.1213/ANE.0000000000004103
|
| 9 |
Trongsakul S , Lambert R , Clark A , Wongpakaran N , Cross J . Development of the Thai version of Mini-Cog, a brief cognitive screening test. Geriatr Gerontol Int, 2015, 15: 594- 600.
doi: 10.1111/ggi.12318
|
| 10 |
Moradi E , Hallikainen I , Hänninen T , Tohka J , Alzheimer's Disease Neuroimaging Initiative . Rey's Auditory Verbal Learning Test scores can be predicted from whole brain MRI in Alzheimer's disease. Neuroimage Clin, 2016, 13: 415- 427.
|
| 11 |
Rao S , Cai Y , Zhong Z , Gou T , Wang Y , Liao S , Qiu P , Kuang W . Prevalence, cognitive characteristics, and influencing factors of amnestic mild cognitive impairment among older adults residing in an urban community in Chengdu, China. Front Neurol, 2024, 15: 1336385.
doi: 10.3389/fneur.2024.1336385
|
| 12 |
Ni XS , Wu F , Song J , An LN , Jiang QW , Bai TT , Wang JY , Yu PL , Zhang CT , Wu JH , Geriatrics Branch of Chinese Medical Association . Chinese expert consensus on assessment for cognitive impairment in the elderly. Zhonghua Lao Nian Yi Xue Za Zhi, 2022, 41: 1430- 1440.
|
|
倪秀石, 吴方, 宋娟, 安丽娜, 蒋倩雯, 白婷婷, 王建业, 于普林, 张存泰, 吴锦晖, 中华医学会老年医学分会. 老年人认知障碍评估中国专家共识(2022). 中华老年医学杂志, 2022, 41: 1430- 1440.
|
| 13 |
Mok EH , Lam LC , Chiu HF . Category verbal fluency test performance in chinese elderly with Alzheimer's disease. Dement Geriatr Cogn Disord, 2004, 18: 120- 124.
doi: 10.1159/000079190
|
| 14 |
Cheung M , Chan AS , Law SC , Chan JH , Tse VK . Cognitive function of patients with nasopharyngeal carcinoma with and without temporal lobe radionecrosis. Arch Neurol, 2000, 57: 1347- 1352.
|
| 15 |
Kasai M , Meguro K , Hashimoto R , Ishizaki J , Yamadori A , Mori E . Non-verbal learning is impaired in very mild Alzheimer's disease (CDR 0.5): normative data from the learning version of the Rey-Osterrieth Complex Figure Test. Psychiatry Clin Neurosci, 2006, 60: 139- 146.
doi: 10.1111/j.1440-1819.2006.01478.x
|
| 16 |
Hong X , Zhang ZX , Wu LY , Shi LL , Zhao XH , Wei J . Validity of complex figure test in differentiation of Alzheimer's disease from non-dementia. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2013, 35: 348- 352.
|
|
洪霞, 张振馨, 武力勇, 史丽丽, 赵晓晖, 魏镜. 复杂图形测验对区分阿尔茨海默病与非痴呆的诊断效度. 中国医学科学院学报, 2013, 35: 348- 352.
|
| 17 |
Huang HC , Tseng YM , Chen YC , Chen PY , Chiu HY . Diagnostic accuracy of the Clinical Dementia Rating Scale for detecting mild cognitive impairment and dementia: a bivariate meta-analysis. Int J Geriatr Psychiatry, 2021, 36: 239- 251.
doi: 10.1002/gps.5436
|
| 18 |
Hughes CP , Berg L , Danziger WL , Coben LA , Martin RL . A new clinical scale for the staging of dementia. Br J Psychiatry, 1982, 140: 566- 572.
doi: 10.1192/bjp.140.6.566
|
| 19 |
Rosen WG , Mohs RC , Davis KL . A new rating scale for Alzheimer's disease. Am J Psychiatry, 1984, 141: 1356- 1364.
doi: 10.1176/ajp.141.11.1356
|
| 20 |
Kueper JK , Speechley M , Montero-Odasso M . The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog). Modifications and responsiveness in pre-dementia populations: a narrative review. J Alzheimers Dis, 2018, 63: 423- 444.
doi: 10.3233/JAD-170991
|
| 21 |
Cummings JL . The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology, 1997, 48 (5 Suppl 6): S10- S16.
|
| 22 |
Suárez-Calvet M , Araque Caballero MÁ , Kleinberger G , Bateman RJ , Fagan AM , Morris JC , Levin J , Danek A , Ewers M , Haass C , Dominantly Inherited Alzheimer Network . Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury. Sci Transl Med, 2016, 8: 369ra178.
|
| 23 |
Carrozzino D , Patierno C , Fava GA , Guidi J . The Hamilton Rating Scales for Depression: a critical review of clinimetric properties of different versions. Psychother Psychosom, 2020, 89: 133- 150.
doi: 10.1159/000506879
|
| 24 |
Starkstein SE , Jorge R , Mizrahi R , Robinson RG . The construct of minor and major depression in Alzheimer's disease. Am J Psychiatry, 2005, 162: 2086- 2093.
doi: 10.1176/appi.ajp.162.11.2086
|
| 25 |
Lawton MP , Brody EM . Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist, 1969, 9: 179- 186.
doi: 10.1093/geront/9.3_Part_1.179
|
| 26 |
Albert MS , DeKosky ST , Dickson D , Dubois B , Feldman HH , Fox NC , Gamst A , Holtzman DM , Jagust WJ , Petersen RC , Snyder PJ , Carrillo MC , Thies B , Phelps CH . The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 2011, 7: 270- 279.
doi: 10.1016/j.jalz.2011.03.008
|
| 27 |
Pan ZW , Zheng Y , Sun RK , Wang Y , Yue JR , Wang YY . The application of electronic assessment tools for cognitive function. Zhongguo Xun Zheng Yi Xue Za Zhi, 2025, 24: 859- 864.
|
|
潘泽文, 郑燚, 孙锐珂, 王瑜, 岳冀蓉, 王艳艳. 电子认知功能评估工具的应用现状. 中国循证医学杂志, 2025, 24: 859- 864.
|
| 28 |
Henkel C , Seibert S , Nichols Widmann C . Current advances in computerized cognitive assessment for mild cognitive impairment and dementia in older adults: a systematic review. Dement Geriatr Cogn Disord, 2025, 54: 109- 119.
|
| 29 |
Ibanez A , Parra MA , Butler C , Latin America and the Caribbean Consortium on Dementia (LAC-CD) . The Latin America and the Caribbean Consortium on Dementia (LAC-CD): from networking to research to implementation science. J Alzheimers Dis, 2021, 82 (s1): S379- S394.
doi: 10.3233/JAD-201384
|
| 30 |
|
|
|
| 31 |
Tsoy E , Zygouris S , Possin KL . Current state of self-administered brief computerized cognitive assessments for detection of cognitive disorders in older adults: a systematic review. J Prev Alzheimers Dis, 2021, 8: 267- 276.
doi: 10.14283/jpad.2021.11
|
| 32 |
Scharre DW , Chang SI , Nagaraja HN , Vrettos NE , Bornstein RA . Digitally translated Self-Administered Gerocognitive Examination (eSAGE): relationship with its validated paper version, neuropsychological evaluations, and clinical assessments. Alzheimers Res Ther, 2017, 9: 44.
doi: 10.1186/s13195-017-0269-3
|
| 33 |
Berg JL , Durant J , Léger GC , Cummings JL , Nasreddine Z , Miller JB . Comparing the electronic and standard versions of the Montreal Cognitive Assessment in an outpatient memory disorders clinic: a validation study. J Alzheimers Dis, 2018, 62: 93- 97.
doi: 10.3233/JAD-170896
|
| 34 |
Sahakian BJ , Owen AM . Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med, 1992, 85: 399- 402.
|
| 35 |
Darby DG , Pietrzak RH , Fredrickson J , Woodward M , Moore L , Fredrickson A , Sach J , Maruff P . Intraindividual cognitive decline using a brief computerized cognitive screening test. Alzheimers Dement, 2012, 8: 95- 104.
doi: 10.1016/j.jalz.2010.12.009
|
| 36 |
Maruff P , Thomas E , Cysique L , Brew B , Collie A , Snyder P , Pietrzak RH . Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Arch Clin Neuropsychol, 2009, 24: 165- 178.
doi: 10.1093/arclin/acp010
|
| 37 |
Fredrickson J , Maruff P , Woodward M , Moore L , Fredrickson A , Sach J , Darby D . Evaluation of the usability of a brief computerized cognitive screening test in older people for epidemiological studies. Neuroepidemiology, 2010, 34: 65- 75.
doi: 10.1159/000264823
|
| 38 |
Maruff P , Lim YY , Darby D , Ellis KA , Pietrzak RH , Snyder PJ , Bush AI , Szoeke C , Schembri A , Ames D , Masters CL , AIBL Research Group . Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease. BMC Psychol, 2013, 1: 30.
doi: 10.1186/2050-7283-1-30
|
| 39 |
Weintraub S , Dikmen SS , Heaton RK , Tulsky DS , Zelazo PD , Bauer PJ , Carlozzi NE , Slotkin J , Blitz D , Wallner-Allen K , Fox NA , Beaumont JL , Mungas D , Nowinski CJ , Richler J , Deocampo JA , Anderson JE , Manly JJ , Borosh B , Havlik R , Conway K , Edwards E , Freund L , King JW , Moy C , Witt E , Gershon RC . Cognition assessment using the NIH Toolbox. Neurology, 2013, 80 (11 Suppl 3): S54- S64.
|
| 40 |
Buckley RF , Sparks KP , Papp KV , Dekhtyar M , Martin C , Burnham S , Sperling RA , Rentz DM . Computerized cognitive testing for use in clinical trials: a comparison of the NIH Toolbox and Cogstate C3 batteries. J Prev Alzheimers Dis, 2017, 4: 3- 11.
|
| 41 |
Onoda K , Hamano T , Nabika Y , Aoyama A , Takayoshi H , Nakagawa T , Ishihara M , Mitaki S , Yamaguchi T , Oguro H , Shiwaku K , Yamaguchi S . Validation of a new mass screening tool for cognitive impairment: Cognitive Assessment for Dementia, iPad version. Clin Interv Aging, 2013, 8: 353- 360.
|
| 42 |
Zorluoglu G , Kamasak ME , Tavacioglu L , Ozanar PO . A mobile application for cognitive screening of dementia. Comput Methods Programs Biomed, 2015, 118: 252- 262.
doi: 10.1016/j.cmpb.2014.11.004
|
| 43 |
Makizako H , Shimada H , Park H , Doi T , Yoshida D , Uemura K , Tsutsumimoto K , Suzuki T . Evaluation of multidimensional neurocognitive function using a tablet personal computer: test-retest reliability and validity in community-dwelling older adults. Geriatr Gerontol Int, 2013, 13: 860- 866.
doi: 10.1111/ggi.12014
|
| 44 |
Jiang PJ , Tan XL , Yu TT , Cheng X , Peng JJ , Hu S , Li Y , Zhao XM . Application of early recognition screening and diagnostic scale of dementia and cognitive impairment based on electronization. A Er Ci Hai Mo Bing Ji Xiang Guan Bing, 2021, 4: 116- 120.
|
|
蒋平静, 谭小林, 于婷婷, 程雪, 彭晶晶, 胡舒, 李远, 赵新民. 基于电子化的痴呆与认知障碍早期识别筛查和诊断流程的探讨. 阿尔茨海默病及相关病, 2021, 4: 116- 120.
|
| 45 |
Jia ZY , Dong MY , Shi ZS , Jin CL , Li GH . Study of a screening system for mild cognitive impairment based on machine learning model. Shanghai Jiao Tong Da Xue Xue Bao (Yi Xue Ban), 2019, 39: 908- 913.
|
|
贾芷莹, 董旻晔, 施贞夙, 金春林, 李国红. 基于机器学习的轻度认知功能障碍筛查研究. 上海交通大学学报(医学版), 2019, 39: 908- 913.
|
| 46 |
Dubois B , Villain N , Frisoni GB , Rabinovici GD , Sabbagh M , Cappa S , Bejanin A , Bombois S , Epelbaum S , Teichmann M , Habert MO , Nordberg A , Blennow K , Galasko D , Stern Y , Rowe CC , Salloway S , Schneider LS , Cummings JL , Feldman HH . Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group. Lancet Neurol, 2021, 20: 484- 496.
doi: 10.1016/S1474-4422(21)00066-1
|
| 47 |
Valladares-Rodriguez S , Pérez-Rodriguez R , Fernandez-Iglesias JM , Anido-Rifón LE , Facal D , Rivas-Costa C . Learning to detect cognitive impairment through digital games and machine learning techniques. Methods Inf Med, 2018, 57: 197- 207.
doi: 10.3414/ME17-02-0011
|
| 48 |
Jongstra S , Wijsman LW , Cachucho R , Hoevenaar-Blom MP , Mooijaart SP , Richard E . Cognitive testing in people at increased risk of dementia using a smartphone app: the iVitality proof-of-principle study. JMIR Mhealth Uhealth, 2017, 5: e68.
doi: 10.2196/mhealth.6939
|
| 49 |
Takechi H , Yoshino H . Usefulness of CogEvo, a computerized cognitive assessment and training tool, for distinguishing patients with mild Alzheimer's disease and mild cognitive impairment from cognitively normal older people. Geriatr Gerontol Int, 2021, 21: 192- 196.
doi: 10.1111/ggi.14110
|
| 50 |
Nie J , Yang Y , Gao Y , Jiang W , Aidina A , Sun F , Prieto LR , Yu J , Ju K , Song L , Li X . Newly self-administered two-step tool for screening cognitive function in an ageing Chinese population: an exploratory cross-sectional study. Gen Psychiatr, 2023, 36: e100837.
doi: 10.1136/gpsych-2022-100837
|
| 51 |
Chan JYC , Wong A , Yiu B , Mok H , Lam P , Kwan P , Chan A , Mok VCT , Tsoi KKF , Kwok TCY . Electronic cognitive screen technology for screening older adults with dementia and mild cognitive impairment in a community setting: development and validation study. J Med Internet Res, 2020, 22: e17332.
doi: 10.2196/17332
|
| 52 |
Tang Y , Xing Y , Zhu Z , He Y , Li F , Yang J , Liu Q , Li F , Teipel SJ , Zhao G , Jia J . The effects of 7-week cognitive training in patients with vascular cognitive impairment, no dementia (the Cog-VACCINE study): a randomized controlled trial. Alzheimers Dement, 2019, 15: 605- 614.
doi: 10.1016/j.jalz.2019.01.009
|
| 53 |
Li C , Liu Y , Sun JL . Optimization method for infrared eye movement image segmentation. Ji Guang Yu Guang Dian Zi Xue Jin Zhan, 2022, 59: 215- 223.
|
|
李畅, 刘昱, 孙景林. 用于红外眼动图像分割的优化方法. 激光与光电子学进展, 2022, 59: 215- 223.
|
| 54 |
Sun J , Liu Y , Wu H , Jing P , Ji Y . A novel deep learning approach for diagnosing Alzheimer's disease based on eye-tracking data. Front Hum Neurosci, 2022, 16: 972773.
doi: 10.3389/fnhum.2022.972773
|
| 55 |
Sha T , Sun J , Pun S , Liu Y . Monocular 3D gaze estimation using feature discretization and attention mechanism. Optoelectron Lett, 2023, 19: 301- 306.
doi: 10.1007/s11801-023-2203-1
|
| 56 |
Sun J , Wu Z , Wang H , Jing P , Liu Y . A novel integrated eye-tracking system with stereo stimuli for 3-D gaze estimation. IEEE Trans Instrum Meas, 2023, 72: 1- 15.
|
| 57 |
Yin Y , Wang H , Liu S , Sun J , Jing P , Liu Y . Internet of things for diagnosis of Alzheimer's disease: a multimodal machine learning approach based on eye movement features. IEEE Internet of Things Journal, 2023, 10: 11476- 11485.
doi: 10.1109/JIOT.2023.3245067
|
| 58 |
Zuo F , Jing P , Sun J , Duan J , Ji Y , Liu Y . Deep learning-based eye-tracking analysis for diagnosis of Alzheimer's disease using 3D comprehensive visual stimuli. IEEE J Biomed Health Inform, 2024, 28: 2781- 2793.
doi: 10.1109/JBHI.2024.3365172
|
| 59 |
Gold M , Amatniek J , Carrillo MC , Cedarbaum JM , Hendrix JA , Miller BB , Robillard JM , Rice JJ , Soares H , Tome MB , Tarnanas I , Vargas G , Bain LJ , Czaja SJ . Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials. Alzheimers Dement (NY), 2018, 4: 234- 242.
doi: 10.1016/j.trci.2018.04.003
|
| 60 |
Xue C , Kowshik SS , Lteif D , Puducheri S , Jasodanand VH , Zhou OT , Walia AS , Guney OB , Zhang JD , Poésy S , Kaliaev A , Andreu-Arasa VC , Dwyer BC , Farris CW , Hao H , Kedar S , Mian AZ , Murman DL , O'Shea SA , Paul AB , Rohatgi S , Saint-Hilaire MH , Sartor EA , Setty BN , Small JE , Swaminathan A , Taraschenko O , Yuan J , Zhou Y , Zhu S , Karjadi C , Alvin Ang TF , Bargal SA , Plummer BA , Poston KL , Ahangaran M , Au R , Kolachalama VB . AI-based differential diagnosis of dementia etiologies on multimodal data. Nat Med, 2024, 30: 2977- 2989.
doi: 10.1038/s41591-024-03118-z
|
| 61 |
Reyes M , Meier R , Pereira S , Silva CA , Dahlweid FM , von Tengg-Kobligk H , Summers RM , Wiest R . On the interpretability of artificial intelligence in radiology: challenges and opportunities. Radiol Artif Intell, 2020, 2: e190043.
doi: 10.1148/ryai.2020190043
|
| 62 |
Schindler SE , Galasko D , Pereira AC , Rabinovici GD , Salloway S , Suárez-Calvet M , Khachaturian AS , Mielke MM , Udeh-Momoh C , Weiss J , Batrla R , Bozeat S , Dwyer JR , Holzapfel D , Jones DR , Murray JF , Partrick KA , Scholler E , Vradenburg G , Young D , Algeciras-Schimnich A , Aubrecht J , Braunstein JB , Hendrix J , Hu YH , Mattke S , Monane M , Reilly D , Somers E , Teunissen CE , Shobin E , Vanderstichele H , Weiner MW , Wilson D , Hansson O . Acceptable performance of blood biomarker tests of amyloid pathology: recommendations from the Global CEO Initiative on Alzheimer's Disease. Nat Rev Neurol, 2024, 20: 426- 439.
doi: 10.1038/s41582-024-00977-5
|
| 63 |
Knopman DS , DeKosky ST , Cummings JL , Chui H , Corey-Bloom J , Relkin N , Small GW , Miller B , Stevens JC . Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 2001, 56: 1143- 1153.
doi: 10.1212/WNL.56.9.1143
|
| 64 |
Jack CR Jr , Andrews JS , Beach TG , Buracchio T , Dunn B , Graf A , Hansson O , Ho C , Jagust W , McDade E , Molinuevo JL , Okonkwo OC , Pani L , Rafii MS , Scheltens P , Siemers E , Snyder HM , Sperling R , Teunissen CE , Carrillo MC . Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup. Alzheimers Dement, 2024, 20: 5143- 5169.
doi: 10.1002/alz.13859
|
| 65 |
Zetterberg H , Skillbäck T , Mattsson N , Trojanowski JQ , Portelius E , Shaw LM , Weiner MW , Blennow K , Alzheimer's Disease Neuroimaging Initiative . Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression. JAMA Neurol, 2016, 73: 60- 67.
doi: 10.1001/jamaneurol.2015.3037
|
| 66 |
Bellaver B , Ferrari-Souza JP , Uglione da Ros L , Carter SF , Rodriguez-Vieitez E , Nordberg A , Pellerin L , Rosa-Neto P , Leffa DT , Zimmer ER . Astrocyte biomarkers in Alzheimer disease: a systematic review and Meta-analysis. Neurology, 2021, 96: e2944- e2955.
doi: 10.1212/WNL.96.15_supplement.2944
|
| 67 |
Palmqvist S , Zetterberg H , Blennow K , Vestberg S , Andreasson U , Brooks DJ , Owenius R , Hägerström D , Wollmer P , Minthon L , Hansson O . Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography. JAMA Neurol, 2014, 71: 1282- 1289.
doi: 10.1001/jamaneurol.2014.1358
|
| 68 |
Leitão MJ , Silva-Spínola A , Santana I , Olmedo V , Nadal A , Le Bastard N , Baldeiras I . Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer's disease. Alzheimers Res Ther, 2019, 11: 91.
doi: 10.1186/s13195-019-0550-8
|
| 69 |
Palmqvist S , Mattsson N , Hansson O , Alzheimer's Disease Neuroimaging Initiative . Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography. Brain, 2016, 139 (Pt 4): 1226- 1236.
|
| 70 |
Ost M , Nylén K , Csajbok L , Ohrfelt AO , Tullberg M , Wikkelsö C , Nellgård P , Rosengren L , Blennow K , Nellgård B . Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology, 2006, 67: 1600- 1604.
doi: 10.1212/01.wnl.0000242732.06714.0f
|
| 71 |
Blennow K , Hampel H , Weiner M , Zetterberg H . Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol, 2010, 6: 131- 144.
doi: 10.1038/nrneurol.2010.4
|
| 72 |
Buchhave P , Minthon L , Zetterberg H , Wallin AK , Blennow K , Hansson O . Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch Gen Psychiatry, 2012, 69: 98- 106.
doi: 10.1001/archgenpsychiatry.2011.155
|
| 73 |
Janelidze S , Stomrud E , Smith R , Palmqvist S , Mattsson N , Airey DC , Proctor NK , Chai X , Shcherbinin S , Sims JR , Triana-Baltzer G , Theunis C , Slemmon R , Mercken M , Kolb H , Dage JL , Hansson O . Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease. Nat Commun, 2020, 11: 1683.
doi: 10.1038/s41467-020-15436-0
|
| 74 |
Mendes AJ , Ribaldi F , Lathuiliere A , Ashton NJ , Janelidze S , Zetterberg H , Scheffler M , Assal F , Garibotto V , Blennow K , Hansson O , Frisoni GB . Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort. J Neurol, 2024, 271: 2053- 2066.
doi: 10.1007/s00415-023-12148-5
|
| 75 |
Barthélemy NR , Li Y , Joseph-Mathurin N , Gordon BA , Hassenstab J , Benzinger TLS , Buckles V , Fagan AM , Perrin RJ , Goate AM , Morris JC , Karch CM , Xiong C , Allegri R , Mendez PC , Berman SB , Ikeuchi T , Mori H , Shimada H , Shoji M , Suzuki K , Noble J , Farlow M , Chhatwal J , Graff-Radford NR , Salloway S , Schofield PR , Masters CL , Martins RN , O'Connor A , Fox NC , Levin J , Jucker M , Gabelle A , Lehmann S , Sato C , Bateman RJ , McDade E , Dominantly Inherited Alzheimer Network . A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. Nat Med, 2020, 26: 398- 407.
doi: 10.1038/s41591-020-0781-z
|
| 76 |
Mattsson-Carlgren N , Andersson E , Janelidze S , Ossenkoppele R , Insel P , Strandberg O , Zetterberg H , Rosen HJ , Rabinovici G , Chai X , Blennow K , Dage JL , Stomrud E , Smith R , Palmqvist S , Hansson O . Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease. Sci Adv, 2020, 6: eaaz2387.
doi: 10.1126/sciadv.aaz2387
|
| 77 |
Barthélemy NR , Saef B , Li Y , Gordon BA , He Y , Horie K , Stomrud E , Salvadó G , Janelidze S , Sato C , Ovod V , Henson RL , Fagan AM , Benzinger TLS , Xiong C , Morris JC , Hansson O , Bateman RJ , Schindler SE . CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease. Nat Aging, 2023, 3: 391- 401.
doi: 10.1038/s43587-023-00380-7
|
| 78 |
Wisch JK , Gordon BA , Barthélemy NR , Horie K , Henson RL , He Y , Flores S , Benzinger TLS , Morris JC , Bateman RJ , Ances BM , Schindler SE . Predicting continuous amyloid PET values with CSF tau phosphorylation occupancies. Alzheimers Dement, 2024, 20: 6365- 6373.
doi: 10.1002/alz.14132
|
| 79 |
Leuzy A , Mattsson-Carlgren N , Cullen NC , Stomrud E , Palmqvist S , La Joie R , Iaccarino L , Zetterberg H , Rabinovici G , Blennow K , Janelidze S , Hansson O . Robustness of CSF Aβ 42/40 and Aβ42/P-tau181 measured using fully automated immunoassays to detect AD-related outcomes. Alzheimers Dement, 2023, 19: 2994- 3004.
doi: 10.1002/alz.12897
|
| 80 |
Kaplow J , Vandijck M , Gray J , Kanekiyo M , Huyck E , Traynham CJ , Esquivel R , Fagan AM , Luthman J . Concordance of Lumipulse cerebrospinal fluid t-tau/Aβ42 ratio with amyloid PET status. Alzheimers Dement, 2020, 16: 144- 152.
doi: 10.1002/alz.12000
|
| 81 |
Horie K , Barthélemy NR , Sato C , Bateman RJ . CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease. Brain, 2021, 144: 515- 527.
doi: 10.1093/brain/awaa373
|
| 82 |
Horie K , Salvadó G , Barthélemy NR , Janelidze S , Li Y , He Y , Saef B , Chen CD , Jiang H , Strandberg O , Pichet Binette A , Palmqvist S , Sato C , Sachdev P , Koyama A , Gordon BA , Benzinger TLS , Holtzman DM , Morris JC , Mattsson-Carlgren N , Stomrud E , Ossenkoppele R , Schindler SE , Hansson O , Bateman RJ . CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease. Nat Med, 2023, 29: 1954- 1963.
doi: 10.1038/s41591-023-02443-z
|
| 83 |
Hofmann A , Häsler LM , Lambert M , Kaeser SA , Gräber-Sultan S , Obermüller U , Kuder-Buletta E , la Fougere C , Laske C , Vöglein J , Levin J , Fox NC , Ryan NS , Zetterberg H , Llibre-Guerra JJ , Perrin RJ , Ibanez L , Schofield PR , Brooks WS , Day GS , Farlow MR , Allegri RF , Chrem Mendez P , Ikeuchi T , Kasuga K , Lee JH , Roh JH , Mori H , Lopera F , Bateman RJ , McDade E , Gordon BA , Chhatwal JP , Jucker M , Schultz SA , Dominantly Inherited Alzheimer Network . Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer's disease. Nat Commun, 2024, 15: 9982.
doi: 10.1038/s41467-024-52937-8
|
| 84 |
Olsson B , Lautner R , Andreasson U , Öhrfelt A , Portelius E , Bjerke M , Hölttä M , Rosén C , Olsson C , Strobel G , Wu E , Dakin K , Petzold M , Blennow K , Zetterberg H . CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. Lancet Neurol, 2016, 15: 673- 684.
doi: 10.1016/S1474-4422(16)00070-3
|
| 85 |
Benedet AL , Milà-Alomà M , Vrillon A , Ashton NJ , Pascoal TA , Lussier F , Karikari TK , Hourregue C , Cognat E , Dumurgier J , Stevenson J , Rahmouni N , Pallen V , Poltronetti NM , Salvadó G , Shekari M , Operto G , Gispert JD , Minguillon C , Fauria K , Kollmorgen G , Suridjan I , Zimmer ER , Zetterberg H , Molinuevo JL , Paquet C , Rosa-Neto P , Blennow K , Suárez-Calvet M , Translational Biomarkers in Aging and Dementia (TRIAD) study , Alzheimer's and Families (ALFA) study , BioCogBank Paris Lariboisière cohort . Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum. JAMA Neurol, 2021, 78: 1471- 1483.
doi: 10.1001/jamaneurol.2021.3671
|
| 86 |
Teunissen CE , Verberk IMW , Thijssen EH , Vermunt L , Hansson O , Zetterberg H , van der Flier WM , Mielke MM , Del Campo M . Blood-based biomarkers for Alzheimer's disease: towards clinical implementation. Lancet Neurol, 2022, 21: 66- 77.
doi: 10.1016/S1474-4422(21)00361-6
|
| 87 |
Cheng L , Li W , Chen Y , Lin Y , Wang B , Guo Q , Miao Y . Plasma Aβ as a biomarker for predicting Aβ-PET status in Alzheimer's disease: a systematic review with meta-analysis. J Neurol Neurosurg Psychiatry, 2022, 93: 513- 520.
doi: 10.1136/jnnp-2021-327864
|
| 88 |
West T , Kirmess KM , Meyer MR , Holubasch MS , Knapik SS , Hu Y , Contois JH , Jackson EN , Harpstrite SE , Bateman RJ , Holtzman DM , Verghese PB , Fogelman I , Braunstein JB , Yarasheski KE . A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis. Mol Neurodegener, 2021, 16: 30.
doi: 10.1186/s13024-021-00451-6
|
| 89 |
Hu Y , Kirmess KM , Meyer MR , Rabinovici GD , Gatsonis C , Siegel BA , Whitmer RA , Apgar C , Hanna L , Kanekiyo M , Kaplow J , Koyama A , Verbel D , Holubasch MS , Knapik SS , Connor J , Contois JH , Jackson EN , Harpstrite SE , Bateman RJ , Holtzman DM , Verghese PB , Fogelman I , Braunstein JB , Yarasheski KE , West T . Assessment of a plasma amyloid probability score to estimate amyloid positron emission tomography findings among adults with cognitive impairment. JAMA Netw Open, 2022, 5: e228392.
doi: 10.1001/jamanetworkopen.2022.8392
|
| 90 |
Schindler SE , Bollinger JG , Ovod V , Mawuenyega KG , Li Y , Gordon BA , Holtzman DM , Morris JC , Benzinger TLS , Xiong C , Fagan AM , Bateman RJ . High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis. Neurology, 2019, 93: e1647- e1659.
|
| 91 |
Janelidze S , Teunissen CE , Zetterberg H , Allué JA , Sarasa L , Eichenlaub U , Bittner T , Ovod V , Verberk IMW , Toba K , Nakamura A , Bateman RJ , Blennow K , Hansson O . Head-to-head comparison of 8 plasma amyloid-β 42/40 assays in Alzheimer disease. JAMA Neurol, 2021, 78: 1375- 1382.
doi: 10.1001/jamaneurol.2021.3180
|
| 92 |
Karikari TK , Ashton NJ , Brinkmalm G , Brum WS , Benedet AL , Montoliu-Gaya L , Lantero-Rodriguez J , Pascoal TA , Suárez-Calvet M , Rosa-Neto P , Blennow K , Zetterberg H . Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility. Nat Rev Neurol, 2022, 18: 400- 418.
doi: 10.1038/s41582-022-00665-2
|
| 93 |
Janelidze S , Bali D , Ashton NJ , Barthélemy NR , Vanbrabant J , Stoops E , Vanmechelen E , He Y , Dolado AO , Triana-Baltzer G , Pontecorvo MJ , Zetterberg H , Kolb H , Vandijck M , Blennow K , Bateman RJ , Hansson O . Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease. Brain, 2023, 146: 1592- 1601.
doi: 10.1093/brain/awac333
|
| 94 |
Thijssen EH , La Joie R , Strom A , Fonseca C , Iaccarino L , Wolf A , Spina S , Allen IE , Cobigo Y , Heuer H , VandeVrede L , Proctor NK , Lago AL , Baker S , Sivasankaran R , Kieloch A , Kinhikar A , Yu L , Valentin MA , Jeromin A , Zetterberg H , Hansson O , Mattsson-Carlgren N , Graham D , Blennow K , Kramer JH , Grinberg LT , Seeley WW , Rosen H , Boeve BF , Miller BL , Teunissen CE , Rabinovici GD , Rojas JC , Dage JL , Boxer AL , Advancing Research and Treatment for Frontotemporal Lobar Degeneration Investigators . Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Lancet Neurol, 2021, 20: 739- 752.
doi: 10.1016/S1474-4422(21)00214-3
|
| 95 |
Horie K , Salvadó G , Koppisetti RK , Janelidze S , Barthélemy NR , He Y , Sato C , Gordon BA , Jiang H , Benzinger TLS , Stomrud E , Holtzman DM , Mattsson-Carlgren N , Morris JC , Palmqvist S , Ossenkoppele R , Schindler SE , Hansson O , Bateman RJ . Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer's disease. Nat Med, 2025, 31: 2044- 2053.
doi: 10.1038/s41591-025-03617-7
|
| 96 |
Therriault J , Vermeiren M , Servaes S , Tissot C , Ashton NJ , Benedet AL , Karikari TK , Lantero-Rodriguez J , Brum WS , Lussier FZ , Bezgin G , Stevenson J , Rahmouni N , Kunach P , Wang YT , Fernandez-Arias J , Socualaya KQ , Macedo AC , Ferrari-Souza JP , Ferreira PCL , Bellaver B , Leffa DT , Zimmer ER , Vitali P , Soucy JP , Triana-Baltzer G , Kolb HC , Pascoal TA , Saha-Chaudhuri P , Gauthier S , Zetterberg H , Blennow K , Rosa-Neto P . Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography. JAMA Neurol, 2023, 80: 188- 199.
doi: 10.1001/jamaneurol.2022.4485
|
| 97 |
Pichet Binette A , Franzmeier N , Spotorno N , Ewers M , Brendel M , Biel D , Alzheimer's Disease Neuroimaging Initiative , Strandberg O , Janelidze S , Palmqvist S , Mattsson-Carlgren N , Smith R , Stomrud E , Ossenkoppele R , Hansson O . Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's disease. Nat Commun, 2022, 13: 6635.
doi: 10.1038/s41467-022-34129-4
|
| 98 |
Mattsson-Carlgren N , Janelidze S , Palmqvist S , Cullen N , Svenningsson AL , Strandberg O , Mengel D , Walsh DM , Stomrud E , Dage JL , Hansson O . Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease. BrainJ, 2020, 143: 3234- 3241.
doi: 10.1093/brain/awaa286
|
| 99 |
Therriault J , Brum WS , Trudel L , Macedo AC , Bitencourt FV , Martins-Pfeifer CC , Nakouzi M , Pola I , Wong M , Kac PR , Real AP , Witherow C , Karikari TK , Moscoso A , Zimmer ER , Schöll M , Pascoal T , Benedet AL , Ashton NJ , Schindler SE , Zetterberg H , Blennow K , Rosa-Neto P . Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. Lancet Neurol, 2025, 24: 740- 752.
doi: 10.1016/S1474-4422(25)00227-3
|
| 100 |
Warmenhoven N , Salvadó G , Janelidze S , Mattsson-Carlgren N , Bali D , Orduña Dolado A , Kolb H , Triana-Baltzer G , Barthélemy NR , Schindler SE , Aschenbrenner AJ , Raji CA , Benzinger TLS , Morris JC , Ibanez L , Timsina J , Cruchaga C , Bateman RJ , Ashton N , Arslan B , Zetterberg H , Blennow K , Pichet Binette A , Hansson O . A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests. Brain, 2025, 148: 416- 431.
doi: 10.1093/brain/awae346
|
| 101 |
Groot C , Cicognola C , Bali D , Triana-Baltzer G , Dage JL , Pontecorvo MJ , Kolb HC , Ossenkoppele R , Janelidze S , Hansson O . Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217. Alzheimers Res Ther, 2022, 14: 67.
doi: 10.1186/s13195-022-01005-8
|
| 102 |
Janelidze S , Berron D , Smith R , Strandberg O , Proctor NK , Dage JL , Stomrud E , Palmqvist S , Mattsson-Carlgren N , Hansson O . Associations of plasma phospho-tau217 levels with tau positron emission tomography in early Alzheimer disease. JAMA Neurol, 2021, 78: 149- 156.
doi: 10.1001/jamaneurol.2020.4201
|
| 103 |
Barthélemy NR , Salvadó G , Schindler SE , He Y , Janelidze S , Collij LE , Saef B , Henson RL , Chen CD , Gordon BA , Li Y , La Joie R , Benzinger TLS , Morris JC , Mattsson-Carlgren N , Palmqvist S , Ossenkoppele R , Rabinovici GD , Stomrud E , Bateman RJ , Hansson O . Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests. Nat Med, 2024, 30: 1085- 1095.
doi: 10.1038/s41591-024-02869-z
|
| 104 |
Zhong X , Wang Q , Yang M , Lin G , Yao K , Wu Z , Xu D , Zhou H , Chen B , Shi H , Zhang M , Shi X , Zeng Y , Lao J , Liang S , Li J , Liu Q , Liu H , Chen Y , Lin Y , Ouyang C , Lv J , Liang X , Cheng Y , Ran P , Gong B , Zhang B , Guo J , Zhang H , Liu S , Zhang J , Liu H , Ning Y . Plasma p-tau217 and p-tau217/Aβ1-42 are effective biomarkers for identifying CSF- and PET imaging-diagnosed Alzheimer's disease: insights for research and clinical practice. Alzheimers Dement, 2025, 21: e14536.
doi: 10.1002/alz.14536
|
| 105 |
Karikari TK , Pascoal TA , Ashton NJ , Janelidze S , Benedet AL , Rodriguez JL , Chamoun M , Savard M , Kang MS , Therriault J , Schöll M , Massarweh G , Soucy JP , Höglund K , Brinkmalm G , Mattsson N , Palmqvist S , Gauthier S , Stomrud E , Zetterberg H , Hansson O , Rosa-Neto P , Blennow K . Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol, 2020, 19: 422- 433.
doi: 10.1016/S1474-4422(20)30071-5
|
| 106 |
Doecke JD , Bellomo G , Vermunt L , Alcolea D , Halbgebauer S , In't Veld S , Mattsson-Carlgren N , Veverova K , Fowler CJ , Boonkamp L , Houtkamp IM , Koel-Simmerlink M , Verberk IMW , Gaetani L , Toja A , Wojdała AL , Fortea J , Pijnenburg Y , Lemstra A , van der Flier W , Hort J , Otto M , Hansson O , Parnetti L , Masters CL , Lleó A , González-Escalante A , Contador J , Suárez-Calvet M , Fernández-Lebrero A , Puig-Pijoan A , Ortiz-Romero P , Jiménez-Moyano E , Minguillón C , Del Campo M , Teunissen C . Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: an international multi-center study. Alzheimers Dement, 2025, 21: e14573.
doi: 10.1002/alz.14573
|
| 107 |
Park MK , Ahn J , Lim JM , Han M , Lee JW , Lee JC , Hwang SJ , Kim KC . A transcriptomics-based machine learning model discriminating mild cognitive impairment and the prediction of conversion to Alzheimer's disease. Cells, 2024, 13: 1920.
doi: 10.3390/cells13221920
|
| 108 |
Ashton NJ , Pascoal TA , Karikari TK , Benedet AL , Lantero-Rodriguez J , Brinkmalm G , Snellman A , Schöll M , Troakes C , Hye A , Gauthier S , Vanmechelen E , Zetterberg H , Rosa-Neto P , Blennow K . Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology. Acta Neuropathol, 2021, 141: 709- 724.
doi: 10.1007/s00401-021-02275-6
|
| 109 |
Jiao B , Ouyang Z , Liu Y , Zhang C , Xu T , Yang Q , Zhang S , Zhu Y , Wan M , Xiao X , Liu X , Zhou Y , Liao X , Zhang W , Luo S , Tang B , Shen L . Evaluating the diagnostic performance of six plasma biomarkers for Alzheimer's disease and other neurodegenerative dementias in a large Chinese cohort. Alzheimers Res Ther, 2025, 17: 71.
doi: 10.1186/s13195-025-01712-y
|
| 110 |
Ferreira PCL , Therriault J , Tissot C , Ferrari-Souza JP , Benedet AL , Povala G , Bellaver B , Leffa DT , Brum WS , Lussier FZ , Bezgin G , Servaes S , Vermeiren M , Macedo AC , Cabrera A , Stevenson J , Triana-Baltzer G , Kolb H , Rahmouni N , Klunk WE , Lopez OL , Villemagne VL , Cohen A , Tudorascu DL , Zimmer ER , Karikari TK , Ashton NJ , Zetterberg H , Blennow K , Gauthier S , Rosa-Neto P , Pascoal TA . Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals. Alzheimers Dement, 2023, 19: 4463- 4474.
doi: 10.1002/alz.13393
|
| 111 |
Preische O , Schultz SA , Apel A , Kuhle J , Kaeser SA , Barro C , Gräber S , Kuder-Buletta E , LaFougere C , Laske C , Vöglein J , Levin J , Masters CL , Martins R , Schofield PR , Rossor MN , Graff-Radford NR , Salloway S , Ghetti B , Ringman JM , Noble JM , Chhatwal J , Goate AM , Benzinger TLS , Morris JC , Bateman RJ , Wang G , Fagan AM , McDade EM , Gordon BA , Jucker M , Dominantly Inherited Alzheimer Network . Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease. Nat Med, 2019, 25: 277- 283.
doi: 10.1038/s41591-018-0304-3
|
| 112 |
Fuloria NK , Sekar M , Porwal O , Ansari MT , Biswas A , Narain K , Biswas S , Bhatia S , Dhanalekshmi UM , Fuloria S . Neurofilament light chain in Alzheimer's disease. Clin Chim Acta, 2026, 578: 120580.
doi: 10.1016/j.cca.2025.120580
|
| 113 |
Weston PSJ , Poole T , Ryan NS , Nair A , Liang Y , Macpherson K , Druyeh R , Malone IB , Ahsan RL , Pemberton H , Klimova J , Mead S , Blennow K , Rossor MN , Schott JM , Zetterberg H , Fox NC . Serum neurofilament light in familial Alzheimer disease: a marker of early neurodegeneration. Neurology, 2017, 89: 2167- 2175.
doi: 10.1212/WNL.0000000000004667
|
| 114 |
Rohrer JD , Woollacott IO , Dick KM , Brotherhood E , Gordon E , Fellows A , Toombs J , Druyeh R , Cardoso MJ , Ourselin S , Nicholas JM , Norgren N , Mead S , Andreasson U , Blennow K , Schott JM , Fox NC , Warren JD , Zetterberg H . Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia. Neurology, 2016, 87: 1329- 1336.
doi: 10.1212/WNL.0000000000003154
|
| 115 |
Rojas JC , Karydas A , Bang J , Tsai RM , Blennow K , Liman V , Kramer JH , Rosen H , Miller BL , Zetterberg H , Boxer AL . Plasma neurofilament light chain predicts progression in progressive supranuclear palsy. Ann Clin Transl Neurol, 2016, 3: 216- 225.
doi: 10.1002/acn3.290
|
| 116 |
Guo Y , You J , Zhang Y , Liu WS , Huang YY , Zhang YR , Zhang W , Dong Q , Feng JF , Cheng W , Yu JT . Plasma proteomic profiles predict future dementia in healthy adults. Nat Aging, 2024, 4: 247- 260.
doi: 10.1038/s43587-023-00565-0
|
| 117 |
Kim KY , Shin KY , Chang KA . GFAP as a potential biomarker for Alzheimer's disease: a systematic review and Meta-analysis. Cells, 2023, 12: 1309.
doi: 10.3390/cells12091309
|
| 118 |
Palmqvist S , Whitson HE , Allen LA , Suarez-Calvet M , Galasko D , Karikari TK , Okrahvi HR , Paczynski M , Schindler SE , Teunissen CE , Zetterberg H , Carrillo MC , Edelmayer RM , Mahinrad S , McAteer MB , Kahale LA , Pahlke S , Tampi MP . Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings. Alzheimers Dement, 2025, 21: e70535.
doi: 10.1002/alz.70535
|
| 119 |
Sepehry AA , Lang D , Hsiung GY , Rauscher A . Prevalence of brain microbleeds in Alzheimer disease: a systematic review and Meta-analysis on the influence of neuroimaging techniques. AJNR Am J Neuroradiol, 2016, 37: 215- 222.
doi: 10.3174/ajnr.A4525
|
| 120 |
Cogswell PM , Barakos JA , Barkhof F , Benzinger TS , Jack CR Jr , Poussaint TY , Raji CA , Ramanan VK , Whitlow CT . Amyloid-related imaging abnormalities with emerging Alzheimer disease therapeutics: detection and reporting recommendations for clinical practice. AJNR Am J Neuroradiol, 2022, 43: E19- E35.
doi: 10.3174/ajnr.A7586
|
| 121 |
Sima DM , Phan TV , Franceschi AM , Gibbs WN , Barkhof F , Scheltens P , Salloway S , Cummings J , Van Hecke W , Smeets D . Monitoring of amyloid related imaging abnormalities: SWI vs T2*-GRE. J Prev Alzheimers Dis, 2025, 12: 100220.
doi: 10.1016/j.tjpad.2025.100220
|
| 122 |
Expert Consensus Review Committee on Disease-Modifying Treatments for Early Alzheimer's Disease . Recommendations for the disease-modifying treatments of early Alzheimer's disease. Zhonghua Nei Ke Za Zhi, 2025, 64: 385- 395.
|
|
《早期阿尔茨海默病疾病修饰治疗专家共识》编审委员会. 早期阿尔茨海默病疾病修饰治疗专家共识. 中华内科杂志, 2025, 64: 385- 395.
|
| 123 |
Qin L , Guo Z , McClure MA , Mu Q . White matter changes from mild cognitive impairment to Alzheimer's disease: a meta-analysis. Acta Neurol Belg, 2021, 121: 1435- 1447.
doi: 10.1007/s13760-020-01322-5
|
| 124 |
Promteangtrong C , Kolber M , Ramchandra P , Moghbel M , Houshmand S , Schöll M , Bai H , Werner TJ , Alavi A , Buchpiguel C . Multimodality imaging approach in Alzheimer disease. Part Ⅰ : structural MRI, functional MRI, diffusion tensor imaging and magnetization transfer imaging. Dement Neuropsychol, 2015, 9: 318- 329.
doi: 10.1590/1980-57642015DN94000318
|
| 125 |
Bernetti C , D'Andrea V , Buoso A , Barbalace I , Greco F , Pilato F , Calandrelli R , Di Lazzaro V , Zobel BB , Mallio CA . Arterial spin labeling MRI in Alzheimer's disease: a systematic review of cerebral perfusion biomarkers. J Neuroimaging, 2025, 35: e70035.
doi: 10.1111/jon.70035
|
| 126 |
Morgan CA , Melzer TR , Roberts RP , Wiebels K , Mutsaerts HJMM , Spriggs MJ , Dalrymple-Alford JC , Anderson TJ , Cutfield NJ , Deib G , Pfeuffer J , Addis DR , Kirk IJ , Tippett LJ . Spatial variation of perfusion MRI reflects cognitive decline in mild cognitive impairment and early dementia. Sci Rep, 2021, 11: 23325.
doi: 10.1038/s41598-021-02313-z
|
| 127 |
Nedelska Z , Senjem ML , Przybelski SA , Lesnick TG , Lowe VJ , Boeve BF , Arani A , Vemuri P , Graff-Radford J , Ferman TJ , Jones DT , Savica R , Knopman DS , Petersen RC , Jack CR , Kantarci K . Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: associations with clinical severity, glucose metabolism and tau PET. Neuroimage Clin, 2018, 19: 939- 947.
doi: 10.1016/j.nicl.2018.06.020
|
| 128 |
Steketee RM , Bron EE , Meijboom R , Houston GC , Klein S , Mutsaerts HJ , Mendez Orellana CP , de Jong FJ , van Swieten JC , van der Lugt A , Smits M . Early-stage differentiation between presenile Alzheimer's disease and frontotemporal dementia using arterial spin labeling MRI. Eur Radiol, 2016, 26: 244- 253.
doi: 10.1007/s00330-015-3789-x
|
| 129 |
Klunk WE , Engler H , Nordberg A , Wang Y , Blomqvist G , Holt DP , Bergström M , Savitcheva I , Huang GF , Estrada S , Ausén B , Debnath ML , Barletta J , Price JC , Sandell J , Lopresti BJ , Wall A , Koivisto P , Antoni G , Mathis CA , Långström B . Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol, 2004, 55: 306- 319.
doi: 10.1002/ana.20009
|
| 130 |
Rabinovici GD , Knopman DS , Arbizu J , Benzinger TLS , Donohoe KJ , Hansson O , Herscovitch P , Kuo PH , Lingler JH , Minoshima S , Murray ME , Price JC , Salloway SP , Weber CJ , Carrillo MC , Johnson KA . Updated appropriate use criteria for amyloid and tau PET: a report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup. Alzheimers Dement, 2025, 21: e14338.
doi: 10.1002/alz.14338
|
| 131 |
Collij LE , Bischof GN , Altomare D , Vállez García D , Alves IL , Battle MR , Hegde M , Wolz R , Gismondi R , Stephens AW , Walker Z , Scheltens P , Nordberg AK , Gispert DJ , Farrar G , Drzezga A , Perissinotti A , Morbelli S , Buckley C , Garibotto V , Frisoni GB , Barkhof F , The AMYPAD Consortium . Quantification supports visual assessment of challenging amyloid-PET images. Alzheimers Dement, 2023, 19 (S17): e074620.
doi: 10.1002/alz.074620
|
| 132 |
van der Kant R , Goldstein LSB , Ossenkoppele R . Amyloid-β-independent regulators of tau pathology in Alzheimer disease. Nat Rev Neurosci, 2020, 21: 21- 35.
doi: 10.1038/s41583-019-0240-3
|
| 133 |
Braak H , Braak E . Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol, 1991, 82: 239- 259.
doi: 10.1007/BF00308809
|
| 134 |
Leuzy A , Raket LL , Villemagne VL , Klein G , Tonietto M , Olafson E , Baker S , Saad ZS , Bullich S , Lopresti B , Bohorquez SS , Boada M , Betthauser TJ , Charil A , Collins EC , Collins JA , Cullen N , Gunn RN , Higuchi M , Hostetler E , Hutchison RM , Iaccarino L , Insel PS , Irizarry MC , Jack CR Jr , Jagust WJ , Johnson KA , Johnson SC , Karten Y , Marquié M , Mathotaarachchi S , Mintun MA , Ossenkoppele R , Pappas I , Petersen RC , Rabinovici GD , Rosa-Neto P , Schwarz CG , Smith R , Stephens AW , Whittington A , Carrillo MC , Pontecorvo MJ , Haeberlein SB , Dunn B , Kolb HC , Sivakumaran S , Rowe CC , Hansson O , Doré V . Harmonizing tau positron emission tomography in Alzheimer's disease: the CenTauR scale and the joint propagation model. Alzheimers Dement, 2024, 20: 5833- 5848.
doi: 10.1002/alz.13908
|
| 135 |
Babiloni C , Arakaki X , Azami H , Bennys K , Blinowska K , Bonanni L , Bujan A , Carrillo MC , Cichocki A , de Frutos-Lucas J , Del Percio C , Dubois B , Edelmayer R , Egan G , Epelbaum S , Escudero J , Evans A , Farina F , Fargo K , Fernández A , Ferri R , Frisoni G , Hampel H , Harrington MG , Jelic V , Jeong J , Jiang Y , Kaminski M , Kavcic V , Kilborn K , Kumar S , Lam A , Lim L , Lizio R , Lopez D , Lopez S , Lucey B , Maestú F , McGeown WJ , McKeith I , Moretti DV , Nobili F , Noce G , Olichney J , Onofrj M , Osorio R , Parra-Rodriguez M , Rajji T , Ritter P , Soricelli A , Stocchi F , Tarnanas I , Taylor JP , Teipel S , Tucci F , Valdes-Sosa M , Valdes-Sosa P , Weiergräber M , Yener G , Guntekin B . Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: recommendations of an expert panel. Alzheimers Dement, 2021, 17: 1528- 1553.
doi: 10.1002/alz.12311
|
| 136 |
Rossini PM , Di Iorio R , Vecchio F , Anfossi M , Babiloni C , Bozzali M , Bruni AC , Cappa SF , Escudero J , Fraga FJ , Giannakopoulos P , Guntekin B , Logroscino G , Marra C , Miraglia F , Panza F , Tecchio F , Pascual-Leone A , Dubois B . Early diagnosis of Alzheimer's disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts. Clin Neurophysiol, 2020, 131: 1287- 1310.
doi: 10.1016/j.clinph.2020.03.003
|
| 137 |
Babiloni C , Arakaki X , Baez S , Barry RJ , Benussi A , Blinowska K , Bonanni L , Borroni B , Bayard JB , Bruno G , Cacciotti A , Carducci F , Carino J , Carpi M , Conte A , Cruzat J , D'Antonio F , Della Penna S , Del Percio C , De Sanctis P , Escudero J , Fabbrini G , Farina FR , Fraga FJ , Fuhr P , Gschwandtner U , Güntekin B , Guo Y , Hajos M , Hallett M , Hampel H , Hanoğlu L , Haraldsen I , Hassan M , Hatlestad-Hall C , Horváth AA , Ibanez A , Infarinato F , Jaramillo-Jimenez A , Jeong J , Jiang Y , Kamiński M , Koch G , Kumar S , Leodori G , Li G , Lizio R , Lopez S , Ferri R , Maestú F , Marra C , Marzetti L , McGeown W , Miraglia F , Moguilner S , Moretti DV , Mushtaq F , Noce G , Nucci L , Ochoa J , Onorati P , Padovani A , Pappalettera C , Parra MA , Pardini M , Pascual-Marqui R , Paulus W , Pizzella V , Prado P , Rauchs G , Ritter P , Salvatore M , Santamaria-García H , Schirner M , Soricelli A , Taylor JP , Tankisi H , Tecchio F , Teipel S , Kodamullil AT , Triggiani AI , Valdes-Sosa M , Valdes-Sosa P , Vecchio F , Vossel K , Yao D , Yener G , Ziemann U , Kamondi A . Alpha rhythm and Alzheimer's disease: Has Hans Berger's dream come true?. Clin Neurophysiol, 2025, 172: 33- 50.
doi: 10.1016/j.clinph.2025.02.256
|
| 138 |
Jovicich J , Babiloni C , Ferrari C , Marizzoni M , Moretti DV , Del Percio C , Lizio R , Lopez S , Galluzzi S , Albani D , Cavaliere L , Minati L , Didic M , Fiedler U , Forloni G , Hensch T , Molinuevo JL , Bartrés Faz D , Nobili F , Orlandi D , Parnetti L , Farotti L , Costa C , Payoux P , Rossini PM , Marra C , Schönknecht P , Soricelli A , Noce G , Salvatore M , Tsolaki M , Visser PJ , Richardson JC , Wiltfang J , Bordet R , Blin O , Frisoniand GB , The PharmaCog Consortium . Two-year longitudinal monitoring of amnestic mild cognitive impairment patients with prodromal Alzheimer's disease using topographical biomarkers derived from functional magnetic resonance imaging and electroencephalographic activity. J Alzheimers Dis, 2019, 69: 15- 35.
doi: 10.3233/JAD-180158
|
| 139 |
Jelic V , Johansson SE , Almkvist O , Shigeta M , Julin P , Nordberg A , Winblad B , Wahlund LO . Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging, 2000, 21: 533- 540.
doi: 10.1016/S0197-4580(00)00153-6
|
| 140 |
Jelic V , Dierks T , Amberla K , Almkvist O , Winblad B , Nordberg A . Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease. Neurosci Lett, 1998, 254: 85- 88.
doi: 10.1016/S0304-3940(98)00669-7
|
| 141 |
Liedorp M , van der Flier WM , Hoogervorst EL , Scheltens P , Stam CJ . Associations between patterns of EEG abnormalities and diagnosis in a large memory clinic cohort. Dement Geriatr Cogn Disord, 2009, 27: 18- 23.
doi: 10.1159/000182422
|
| 142 |
Babiloni C , Cassetta E , Dal Forno G , Del Percio C , Ferreri F , Ferri R , Lanuzza B , Miniussi C , Moretti DV , Nobili F , Pascual-Marqui RD , Rodriguez G , Luca Romani G , Salinari S , Zanetti O , Rossini PM . Donepezil effects on sources of cortical rhythms in mild Alzheimer's disease: responders vs. non-responders. Neuroimage, 2006, 31: 1650- 1665.
doi: 10.1016/j.neuroimage.2006.02.015
|
| 143 |
Khan W , Khan MS , Qasem SN , Ghaban W , Saeed F , Hanif M , Ahmad J . An explainable and efficient deep learning framework for EEG-based diagnosis of Alzheimer's disease and frontotemporal dementia. Front Med (Lausanne), 2025, 12: 1590201.
|
| 144 |
Chen R , Zhang J , Wu Y , Wang D , Feng G , Tang YP , Teng Z , Chen C . Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease. Cell Rep, 2012, 2: 1329- 1339.
doi: 10.1016/j.celrep.2012.09.030
|
| 145 |
Serrano-Pozo A , Das S , Hyman BT . APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol, 2021, 20: 68- 80.
doi: 10.1016/S1474-4422(20)30412-9
|
| 146 |
Cummings J , Apostolova L , Rabinovici GD , Atri A , Aisen P , Greenberg S , Hendrix S , Selkoe D , Weiner M , Petersen RC , Salloway S . Lecanemab: appropriate use recommendations. J Prev Alzheimers Dis, 2023, 10: 362- 377.
doi: 10.14283/jpad.2023.30
|